Santen Pharmaceutical Co Stock Buy Hold or Sell Recommendation
| SNPHY Stock | USD 9.68 0.03 0.31% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Santen Pharmaceutical Co is 'Strong Sell'. Macroaxis provides Santen Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SNPHY positions. The advice algorithm takes into account all of Santen Pharmaceutical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Santen Pharmaceutical's buy or sell advice are summarized below:
Real Value 8.74 | Hype Value 9.68 | Market Value 9.68 | Naive Value 9.66 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Santen Pharmaceutical Co given historical horizon and risk tolerance towards Santen Pharmaceutical. When Macroaxis issues a 'buy' or 'sell' recommendation for Santen Pharmaceutical Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Santen |
Execute Santen Pharmaceutical Buy or Sell Advice
The Santen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Santen Pharmaceutical Co. Macroaxis does not own or have any residual interests in Santen Pharmaceutical Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Santen Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Santen Pharmaceutical Trading Alerts and Improvement Suggestions
| Santen Pharmaceutical generated a negative expected return over the last 90 days |
Santen Pharmaceutical Returns Distribution Density
The distribution of Santen Pharmaceutical's historical returns is an attempt to chart the uncertainty of Santen Pharmaceutical's future price movements. The chart of the probability distribution of Santen Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Santen Pharmaceutical Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Santen Pharmaceutical returns is essential to provide solid investment advice for Santen Pharmaceutical.
| Mean Return | 0 | Value At Risk | -3.9 | Potential Upside | 4.05 | Standard Deviation | 2.55 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Santen Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Santen Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Santen Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Santen Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Santen pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.05 | |
β | Beta against NYSE Composite | 0.46 | |
σ | Overall volatility | 2.60 | |
Ir | Information ratio | -0.04 |
Santen Pharmaceutical Volatility Alert
Santen Pharmaceutical Co currently demonstrates below-average downside deviation. It has Information Ratio of -0.04 and Jensen Alpha of -0.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Santen Pharmaceutical's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Santen Pharmaceutical's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Santen Pharmaceutical Fundamentals Vs Peers
Comparing Santen Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Santen Pharmaceutical's direct or indirect competition across all of the common fundamentals between Santen Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Santen Pharmaceutical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Santen Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Santen Pharmaceutical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Santen Pharmaceutical to competition |
| Fundamentals | Santen Pharmaceutical | Peer Average |
| Return On Equity | -0.0264 | -0.31 |
| Return On Asset | -0.001 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | (0) % | (5.51) % |
| Current Valuation | 2.6 B | 16.62 B |
| Shares Outstanding | 388.22 M | 571.82 M |
| Shares Owned By Institutions | 0.02 % | 39.21 % |
| Price To Earning | 14.22 X | 28.72 X |
| Price To Book | 1.39 X | 9.51 X |
| Price To Sales | 0.01 X | 11.42 X |
| Revenue | 266.26 B | 9.43 B |
| Gross Profit | 156.59 B | 27.38 B |
| EBITDA | 53.91 B | 3.9 B |
| Net Income | 27.22 B | 570.98 M |
| Cash And Equivalents | 69.53 B | 2.7 B |
| Cash Per Share | 176.84 X | 5.01 X |
| Total Debt | 32.93 B | 5.32 B |
| Debt To Equity | 0.1 % | 48.70 % |
| Current Ratio | 2.48 X | 2.16 X |
| Book Value Per Share | 780.63 X | 1.93 K |
| Cash Flow From Operations | 46.04 B | 971.22 M |
| Earnings Per Share | 0.47 X | 3.12 X |
| Number Of Employees | 4.32 K | 18.84 K |
| Beta | 0.38 | -0.15 |
| Market Capitalization | 2.94 B | 19.03 B |
| Total Asset | 459.98 B | 29.47 B |
| Retained Earnings | 230.22 B | 9.33 B |
| Working Capital | 106.3 B | 1.48 B |
| Current Asset | 156.63 B | 9.34 B |
| Current Liabilities | 50.32 B | 7.9 B |
| Annual Yield | 0.03 % | |
| Five Year Return | 1.68 % | |
| Net Asset | 459.98 B |
Santen Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Santen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Santen Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell Santen Pharmaceutical Co? Buying financial instruments such as Santen Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Santen Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Santen Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |